{"@type": "dcat:Dataset", "accessLevel": "public", "bureauCode": ["009:25"], "contactPoint": {"@type": "vcard:Contact", "fn": "NIH", "hasEmail": "mailto:info@nih.gov"}, "description": "The recent Cochrane report on albumin administration is analysed and\t\t\t criticised on the grounds of clinical methodology, content and interpretation.\t\t\t Although it is na\u00efve and illogical to treat hypoalbuminaemia with albumin\t\t\t infusions, a more balanced view on the use of albumin for resuscitation in\t\t\t acute hypovolaemia is necessary. Once the acute phase of critical illness is\t\t\t past, interstitial volume is often expanded causing oedema, with a low plasma\t\t\t volume. We argue for the use of salt-poor albumin solutions in this situation\t\t\t and conclude that, on current evidence, the assertion that albumin should be\t\t\t avoided in all situations is irrational and untenable.", "distribution": [{"@type": "dcat:Distribution", "description": "Visit the original government dataset for complete information, documentation, and data access.", "downloadURL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137252/", "mediaType": "text/html", "title": "Official Government Data Source"}], "identifier": "https://healthdata.gov/api/views/dd2r-nfzf", "issued": "2025-07-14", "keyword": ["nih", "albumin-administration", "hypovolemia-resuscitation", "critical-illness", "fluid-resuscitation"], "landingPage": "https://healthdata.gov/d/dd2r-nfzf", "modified": "2025-09-06", "programCode": ["009:048"], "publisher": {"@type": "org:Organization", "name": "National Institutes of Health"}, "theme": ["NIH"], "title": "Debate: Albumin administration should not be avoided"}